Medical / Pharmaceuticals News and Press Releases

Medical / Pharmaceuticals

Releases published in the last 30 days.

Page 1 of 3

Philips expands its patient management solutions in the US with the acquisition of Medumo: 7/19/2019 2:56:56 PM; Royal Philips, a global leader in health technology, today announced that it has expanded its patient management solutions in the US with the acquisition of Boston-based start-up company Medumo.
FDA Approves New Treatment for Complicated Urinary Tract and Complicated Intra-Abdominal Infections: 7/17/2019 11:18:40 AM; The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
Johnson & Johnson Extends Long-Standing Donation Program to Support Global Effort to Tackle Intestinal Worms: 7/16/2019 5:12:40 PM; Johnson & Johnson today announced that it is extending through 2025 global product donations of an intestinal worms treatment made by its Janssen Pharmaceutical Companies.
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101): 7/16/2019 5:04:33 PM; Novartis today announced the US Food and Drug Administration (FDA) accepted the company’s Biologics License Application (BLA) and has granted Priority Review for its investigational sickle cell medicine crizanlizumab (SEG101).
"Sony Research Award Program" Continues for Fourth Year Promoting Innovation and Technological Development with U.S. and Canadian Universities: 7/16/2019 12:19:51 PM; Sony announced today the continuation of the Sony Research Award Program, which provides U.S. and Canadian universities funding for emerging and innovative technology research programs in collaboration with Sony’s own research groups.
Environmental Testing for Fentanyl and Other Illicit Drugs to Protect Emergency Responders: 7/16/2019 11:57:00 AM; In April, U.S. News & World Report published an article that claimed the Department of Homeland Security (DHS) had been considering classifying the drug fentanyl as a weapon of mass destruction.
Grifols presents additional encouraging Alzheimer’s trial results at AAIC: 7/16/2019 10:04:26 AM; The Grifols Clinical Research team, led by Dr. Antonio Páez, presented additional results of its AMBAR (Alzheimer Management by Albumin Replacement) clinical trial for the treatment of Alzheimer’s at the Alzheimer’s Association International Conference (AAIC) 2019 in Los Angeles (USA).
Sobi Invites Entries to First Sobi Scientific Innovation Awards: 7/16/2019 8:55:09 AM; Sobi™ has established the Sobi Scientific Innovation Awards, with a focus on the future of haemophilia care, to recognise innovation and scientific excellence in haemophilia research.
Cholesterol-lowering drugs are under-prescribed for prevention of atherosclerotic cardiovascular disease: 7/16/2019 7:12:50 AM; Statins, the most commonly used effective lipid-lowering drugs, are significantly underutilized to treat lipid abnormalities in patients with and at risk for atherosclerotic cardiovascular disease (ASCVD), according to a retrospective study of more than 280,000 patients in Alberta, Canada.
U.S. Kidney Dialysis Clinics Industry Worth $24 Billion: 7/16/2019; July 15, 2019: Marketdata LLC, a leading independent market research publisher of “off-the-shelf” studies about service industries since 1979, has released a new 82-page study: U.S.
Update on US regulatory decision for Farxiga in type-1 diabetes: 7/15/2019 5:37:02 AM; AstraZeneca announced that the US Food and Drug Administration (FDA) has issued a complete response letter regarding the supplemental New Drug Application for Farxiga (dapagliflozin) as an adjunct treatment to insulin to improve glycaemic control in adult patients with type-1 diabetes (T1D), when insulin alone does not provide adequate glycaemic control.
Moderate calorie restriction in young and middle-aged adults significantly reduces heart and metabolic risk factors independent of weight loss: 7/12/2019 10:52:38 AM; What Moderately reducing caloric intake over a period of two years significantly improved cardiometabolic risk factors in young and middle-aged, non-obese adults, according to new findings from the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) (link is external) trial.
Cyborg-like microchip valve driven by earthworm muscle: 7/11/2019 12:11:50 PM; For several decades, researchers have been trying to combine microelectromechanical systems (MEMS) with living material. Bio-MEMS have many applications, ranging from improved drug delivery and optical and electrochemical sensors to organs-on-chips.
Vaccination to contain severe measles outbreak underway in the Democratic Republic of the Congo amidst Ebola and mass displacement: 7/11/2019 12:05:50 PM; Health workers are urgently rolling out a complex measles vaccination campaign targeting 67,000 children in Ituri, northeast Democratic Republic of the Congo (DRC), a region ravaged by armed conflict that is now also the hub of the second-deadliest Ebola outbreak on record.
Expanding Business and Capital Alliance Contract with HEALIOS K.K. to develop practical applications for regenerative medicine: 7/11/2019 11:49:47 AM; Nikon Corporation (Nikon) agreed on the expansion of partnership between HEALIOS K.K. (Hardy TS Kagimoto, CEO, Tokyo, Japan, hereafter referred to as Healios) based on the business and capital alliance agreement concluded in 2017.
Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment: 7/11/2019 9:30:12 AM; Highlights: • Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis • BioTek is a recognized leader for plate-readers and imaging systems with complementary offerings to Agilent’s portfolio • Excellent growth potential; the acquisition positions Agilent well …
Federal government announces $25 million in funding for the Canadian Institute for Military and Veteran Health Research: 7/11/2019 9:14:26 AM; The Canadian Institute for Military and Veteran Health Research (CIMVHR) and Queen’s University welcomed the Honourable Lawrence MacAulay, Minister of Veterans Affairs and Associate Minister of National Defence, to campus on Wednesday, where he announced a $25 million investment over 10 years to support the institution’s research activities.
International Commission on Clinical Use of Heritable Human Genome Editing to Hold Public Meeting Aug. 13 in Washington, D.C.: 7/10/2019 4:27:36 PM; The International Commission on the Clinical Use of Human Germline Genome Editing is holding its first public meeting on Aug. 13 in Washington, D.C.
Mission Bio Launches in China, Announces Distribution Partnership with Novogene: 7/10/2019 2:32:56 PM; Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, today announced that it has launched sales in China through a distribution agreement with Novogene, a leading provider of genomic services and solutions globally.
Independent Pharmacy Alliance (IPA) Celebrates 31st Anniversary Representing Independent Pharmacy: 7/9/2019 5:01:57 PM; The Independent Pharmacy Alliance (IPA) is celebrating its 31st anniversary representing independent community pharmacy. Since 1988, IPA’s mission is to provide business solutions and advocacy services to help independent pharmacies reduce their cost of goods, increase financial growth and help them continue providing quality patient care.